Cargando…

Inhibition of super enhancer downregulates the expression of KLF5 in basal-like breast cancers

The transcription factor KLF5 (Krüpple-like factor 5) is highly expressed in basal-like breast cancer (BLBC), which promotes cell proliferation, survival, migration and stemness, serving as a potential therapeutic target. In the current study, a super-enhancer (SE) was identified to be located downs...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Chuan-Huizi, Yang, Nong, Zhang, Yongchang, Ding, Jiancheng, Zhang, Wenjuan, Liu, Rong, Liu, Wen, Chen, Ceshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2019
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6643226/ https://www.ncbi.nlm.nih.gov/pubmed/31360115 http://dx.doi.org/10.7150/ijbs.35138

Ejemplares similares

Targeting the KLF5-EphA2 axis can restrain cancer stemness and overcome chemoresistance in basal-like breast cancer
por: Zhao, Ping, et al.
Publicado: (2023)

Mifepristone Suppresses Basal Triple-Negative Breast Cancer Stem Cells by Down-regulating KLF5 Expression
por: Liu, Rong, et al.
Publicado: (2016)

Mifepristone Derivative FZU-00,003 Suppresses Triple-negative Breast Cancer Cell Growth partially via miR-153-KLF5 axis
por: Liu, Rong, et al.
Publicado: (2020)

Histone Deacetylase Inhibitors (HDACi) Promote KLF5 Ubiquitination and Degradation in Basal-like Breast Cancer
por: Kong, Yanjie, et al.
Publicado: (2022)

DNA damage chemotherapeutic drugs suppress basal-like breast cancer growth by down-regulating the transcription of the FOXO1-KLF5 axis
por: Cui, Qiuxia, et al.
Publicado: (2023)

The roles and regulation of the KLF5 transcription factor in cancers
por: Luo, Yao, et al.
Publicado: (2021)

EOFAZ inhibits endothelial-to-mesenchymal transition through downregulation of KLF4
por: Zhang, Yanyan, et al.
Publicado: (2020)

KLF5 inhibition potentiates anti-PD1 efficacy by enhancing CD8(+) T-cell-dependent antitumor immunity
por: Wu, Qi, et al.
Publicado: (2023)

miR-217 inhibits triple-negative breast cancer cell growth, migration, and invasion through targeting KLF5
por: Zhou, Wenhui, et al.
Publicado: (2017)

KLF2 Inhibits the Migration and Invasion of Prostate Cancer Cells by Downregulating MMP2
por: Wang, Binshuai, et al.
Publicado: (2018)

Ataxin-3 like (ATXN3L), a member of the Josephin family of deubiquitinating enzymes, promotes breast cancer proliferation by deubiquitinating Krüppel-like factor 5 (KLF5)
por: Ge, Fei, et al.
Publicado: (2015)

BAP1 promotes breast cancer cell proliferation and metastasis by deubiquitinating KLF5
por: Qin, Junying, et al.
Publicado: (2015)

KLF4 downregulates hTERT expression and telomerase activity to inhibit lung carcinoma growth
por: Hu, Wenxian, et al.
Publicado: (2016)

Metformin suppresses triple-negative breast cancer stem cells by targeting KLF5 for degradation
por: Shi, Peiguo, et al.
Publicado: (2017)

Mithramycin A suppresses basal triple-negative breast cancer cell survival partially via down-regulating Krüppel-like factor 5 transcription by Sp1
por: Liu, Rong, et al.
Publicado: (2018)

Characterization and phylogenetic analysis of Krüppel-like transcription factor (KLF) gene family in tree shrews (Tupaia belangeri chinensis)
por: Shao, Ming, et al.
Publicado: (2016)

The interplay between TEAD4 and KLF5 promotes breast cancer partially through inhibiting the transcription of p27(Kip1)
por: Wang, Chunyan, et al.
Publicado: (2015)

OSMRβ mutants enhance basal keratinocyte differentiation via inactivation of the STAT5/KLF7 axis in PLCA patients
por: Liu, Jun, et al.
Publicado: (2021)

KLF4 Coordinates Corneal Epithelial Apical-Basal Polarity and Plane of Cell Division and Is Downregulated in Ocular Surface Squamous Neoplasia
por: Tiwari, Anil, et al.
Publicado: (2020)

KLF6 inhibited oral cancer migration and invasion via downregulation of mesenchymal markers and inhibition of MMP-9 activities
por: Hsu, Li-Sung, et al.
Publicado: (2017)

The Partial Role of KLF4 and KLF5 in Gastrointestinal Tumors
por: Li, Jun-Chen, et al.
Publicado: (2021)

Downregulation of KLF8 expression by shRNA induces inhibition of cell proliferation in CAL27 human oral cancer cells
por: Bin, Zhang, et al.
Publicado: (2013)

ISG15 is downregulated by KLF12 and implicated in maintenance of cancer stem cell‐like features in cisplatin‐resistant ovarian cancer
por: Zhang, Qi, et al.
Publicado: (2021)

Downregulation of miR-7-5p Inhibits the Tumorigenesis of Esophagus Cancer via Targeting KLF4
por: Shi, Woda, et al.
Publicado: (2020)

LINC00565 Enhances Proliferative Ability in Endometrial Carcinoma by Downregulating KLF9
por: Yin, Xiuyan, et al.
Publicado: (2020)

The KLF14 Transcription Factor Regulates Glycolysis by Downregulating LDHB in Colorectal Cancer
por: Wu, Guiyang, et al.
Publicado: (2019)

ITIH5, a p53-responsive gene, inhibits the growth and metastasis of melanoma cells by downregulating the transcriptional activity of KLF4
por: Liu, Jia, et al.
Publicado: (2021)

Nitazoxanide inhibits acetylated KLF5-induced bone metastasis by modulating KLF5 function in prostate cancer
por: Huang, Qingqing, et al.
Publicado: (2023)

EZH2‐mediated inhibition of KLF14 expression promotes HSCs activation and liver fibrosis by downregulating PPARγ
por: Du, Zhipeng, et al.
Publicado: (2021)

Sp1 and KLF15 regulate basal transcription of the human LRP5 gene
por: Li, Jiangxia, et al.
Publicado: (2010)

LINC00565 Enhances Proliferative Ability in Endometrial Carcinoma by Downregulating KLF9 [Retraction]
Publicado: (2023)

Downregulation of KLF10 contributes to the regeneration of survived renal tubular cells in cisplatin-induced acute kidney injury via ZBTB7A-KLF10-PTEN axis
por: Zhang, Yang, et al.
Publicado: (2023)

Klf5 acetylation regulates luminal differentiation of basal progenitors in prostate development and regeneration
por: Zhang, Baotong, et al.
Publicado: (2020)

Follistatin-Like 1 Is Downregulated in Morbidly and Super Obese Central-European Population
por: Horak, Martin, et al.
Publicado: (2018)

miRNA-576 Alleviates the Malignant Progression of Atherosclerosis through Downregulating KLF5
por: Wang, Jing, et al.
Publicado: (2021)

Knockout of KLF10 Ameliorated Diabetic Renal Fibrosis via Downregulation of DKK-1
por: Hsu, Yung-Chien, et al.
Publicado: (2022)

Therapeutic Targeting of Nonalcoholic Fatty Liver Disease by Downregulating SREBP-1C Expression via AMPK-KLF10 Axis
por: Chen, Yu-Chi, et al.
Publicado: (2021)

Identification and analysis of KLF13 variants in patients with congenital heart disease
por: Li, Wenjuan, et al.
Publicado: (2020)

ABI2‐mediated MEOX2/KLF4‐NANOG axis promotes liver cancer stem cell and drives tumour recurrence
por: Chen, Jiandi, et al.
Publicado: (2022)

Klf4 inhibits tumor growth and metastasis by targeting microRNA-31 in human hepatocellular carcinoma
por: Tian, Chuan, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_656i4rn5jspck0h5urjmukbrok